Breaking News Instant updates and real-time market news.

MTNB

Matinas BioPharma

$1.83 /

+0.19 (+11.59%)

13:16
01/09/20
01/09
13:16
01/09/20
13:16

Matinas BioPharma initiated with a Buy at Aegis

Aegis analyst Nathan Weinstein initiated coverage of Matinas BioPharma with a Buy rating and $3.50 price target.

MTNB Matinas BioPharma
$1.83 /

+0.19 (+11.59%)

11/14/19 BTIG
Amarin AdCom for Vascepa a positive for Omega-3 participant Matinas, says BTIG
06/26/19 H.C. Wainwright
Matinas BioPharma initiated with a Buy at H.C. Wainwright
05/17/19 BTIG
Matinas BioPharma initiated with a Buy at BTIG
02/11/19 Roth Capital
Matinas BioPharma initiated with a Buy at Roth Capital

TODAY'S FREE FLY STORIES

Recommendations
Salesforce price target raised to $220 from $210 at Stifel » 07:42
02/26/20
02/26
07:42
02/26/20
07:42
CRM

Salesforce

$181.65 /

-4.26 (-2.29%)

Stifel analyst Tom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Stratasys sees FY20 EPS 45c-60c, consensus 63c » 07:42
02/26/20
02/26
07:42
02/26/20
07:42
SSYS

Stratasys

$18.28 /

-0.82 (-4.29%)

Sees FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Fossil sees 2020 net sales decline 4.5%-11%, two est. $2.15B  07:42
02/26/20
02/26
07:42
02/26/20
07:42
FOSL

Fossil

$5.31 /

-0.14 (-2.57%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Fossil sees Q1 net sales decline 3.5%-10%, two est. $431.85M  07:41
02/26/20
02/26
07:41
02/26/20
07:41
FOSL

Fossil

$5.31 /

-0.14 (-2.57%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Turning Point Brands sees FY20 revenue $338M-$353M, consensus $341.27M » 07:41
02/26/20
02/26
07:41
02/26/20
07:41
TPB

Turning Point Brands

$22.67 /

-1.13 (-4.75%)

Sees FY20 adj. EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
AudioCodes management to meet with Stephens » 07:41
02/26/20
02/26
07:41
02/26/20
07:41
AUDC

AudioCodes

$24.25 /

-0.14 (-0.57%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Salesforce price target raised to $220 from $210 at Cowen » 07:40
02/26/20
02/26
07:40
02/26/20
07:40
CRM

Salesforce

$181.65 /

-4.26 (-2.29%)

Cowen analyst J. Derrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Fossil sees additional benefits of $65M from NWF 2.0 initiative » 07:40
02/26/20
02/26
07:40
02/26/20
07:40
FOSL

Fossil

$5.31 /

-0.14 (-2.57%)

During 2019, the Company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Stratasys reports Q4 EPS 18c, consensus 20c » 07:40
02/26/20
02/26
07:40
02/26/20
07:40
SSYS

Stratasys

$18.28 /

-0.82 (-4.29%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Cars.com sees FY20 revenue growth positive, consensus $613.96M » 07:39
02/26/20
02/26
07:39
02/26/20
07:39
CARS

Cars.com

$10.57 /

-1.48 (-12.28%)

Expects a sequential…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Fossil reports Q4 EPS (14c), may not compare to two est. 79c » 07:39
02/26/20
02/26
07:39
02/26/20
07:39
FOSL

Fossil

$5.31 /

-0.14 (-2.57%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Turning Point Brands reports Q4 EPS 41c, consensus 46c » 07:39
02/26/20
02/26
07:39
02/26/20
07:39
TPB

Turning Point Brands

$22.67 /

-1.13 (-4.75%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Boise Cascade upgraded to Buy from Neutral at DA Davidson » 07:39
02/26/20
02/26
07:39
02/26/20
07:39
BCC

Boise Cascade

$36.82 /

-3.39 (-8.43%)

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
BioXcel Therapeutics price target raised to $95 from $30 at H.C. Wainwright » 07:38
02/26/20
02/26
07:38
02/26/20
07:38
BTAI

BioXcel Therapeutics

$29.57 /

-2.63 (-8.17%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
RTW Retailwinds announces multi-year partnership with Salesforce » 07:37
02/26/20
02/26
07:37
02/26/20
07:37
RTW

RTW Retailwinds

$0.34 /

-0.0258 (-7.01%)

, CRM

Salesforce

$181.65 /

-4.26 (-2.29%)

RTW Retailwinds (RTW)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Insulet weakness a buying opportunity, says Cowen » 07:37
02/26/20
02/26
07:37
02/26/20
07:37
PODD

Insulet

$197.03 /

-10.46 (-5.04%)

Cowen analyst Ryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Cars.com reports Q4 adjusted EPS 63c, consensus 37c » 07:36
02/26/20
02/26
07:36
02/26/20
07:36
CARS

Cars.com

$10.57 /

-1.48 (-12.28%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Actinium Pharmaceuticals expands CD33 program » 07:36
02/26/20
02/26
07:36
02/26/20
07:36
ATNM

Actinium Pharmaceuticals

$0.23 /

-0.0162 (-6.61%)

Actinium Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Kiniksa expects cash reserves to fund operating plan into 2H21 » 07:36
02/26/20
02/26
07:36
02/26/20
07:36
KNSA

Kiniksa

$17.85 /

-0.73 (-3.93%)

Kiniksa expects that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Revance price target raised to $28 from $23 at H.C. Wainwright » 07:36
02/26/20
02/26
07:36
02/26/20
07:36
RVNC

Revance

$24.77 /

-2.155 (-8.01%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Axcella completes subject enrollment in AXA1665-002 Study » 07:35
02/26/20
02/26
07:35
02/26/20
07:35
AXLA

Axcella

$4.51 /

-0.34 (-7.01%)

Axcella announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Kiniksa expects topline data from Phase 1 trial of KPL-404 in 2H20 » 07:35
02/26/20
02/26
07:35
02/26/20
07:35
KNSA

Kiniksa

$17.85 /

-0.73 (-3.93%)

KPL-404: Kiniksa is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Clean Harbors reports Q4 adj. EPS 42c, consensus 46c » 07:35
02/26/20
02/26
07:35
02/26/20
07:35
CLH

Clean Harbors

$81.66 /

-3.07 (-3.62%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
GW Pharmaceuticals price target lowered to $173 from $203 at Oppenheimer » 07:35
02/26/20
02/26
07:35
02/26/20
07:35
GWPH

GW Pharmaceuticals

$116.77 /

-4.1 (-3.39%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Kiniksa expects data from Phase 2a trial of KPL-716 in April 2020 » 07:35
02/26/20
02/26
07:35
02/26/20
07:35
KNSA

Kiniksa

$17.85 /

-0.73 (-3.93%)

KPL-716: Kiniksa is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.